$2,890,000 of ALTRIA CLIENT SERVICES LLC lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"HR 3838: Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; potential provisions related to tobacco and nicotine products HR 8495: Financial Services and General Government Appropriations Act, 2027; related to provisions to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products HR 8595: National Security, Department of State, and Related Programs Appropriations Act, 2027; related to provisions to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products HR 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2027; Section 766, related to provisions regarding the regulation of tobacco products and provisions to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products HR 8845/S 2354: Commerce Justice Science and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 9170: Transportation Housing and Urban Development and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 9260/S 2587: Departments of Labor, Health and Human Services and Education and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 9310: Department of Homeland Security Appropriations Act 2027; potential provisions related to tobacco and nicotine products S 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products S 2296: National Defense Authorization Act for Fiscal Year 2026; potential provisions related to tobacco and nicotine products S 2587: Departments of Labor Health and Human Services and Education and Related Agencies Appropriations Act 2026; potential provisions related to tobacco and nicotine products HR 1798/ S 819: End Tobacco Loopholes Act; all provisions of the bill HR 3838: Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; provisions relating to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products HR 6845: S.T.O.P. Illicit Vapes Act Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction and pathways to authorization for tobacco and nicotine products Discussions concerning proposals to ban characterizing flavors in tobacco products Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products Discussions concerning nicotine analogue products and FDAs regulatory authority over such products Discussions regarding federal excise taxes and the taxation of tobacco products HR 6845: S.T.O.P. Illicit Vapes Act; all provisions of the bill S 4303: ENDS Chinese Vapes Act of 2026; all provisions of the bill Discussions related to FDA Guidance on Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization HR 10068/S 5312 PROTECT Act; all provisions of the bill S 4257 Resources To Prevent Youth Vaping Act; all provisions of the bill"
You can find more data on corporate lobbying on Quiver Quantitative.
MO Insider Trading Activity
MO insiders have traded $MO stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MO stock by insiders over the last 6 months:
- ENNIS DEBRA J KELLY sold 5,790 shares for an estimated $418,317
- ELLEN R STRAHLMAN sold 2,000 shares for an estimated $145,118
- KATHRYN B. MCQUADE purchased 1,500 shares for an estimated $101,430
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
MO Hedge Fund Activity
We have seen 1,284 institutional investors add shares of MO stock to their portfolio, and 959 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 59,122,097 shares (+inf%) to their portfolio in Q2 2026, for an estimated $4,253,834,879
- CAPITAL RESEARCH GLOBAL INVESTORS added 32,973,712 shares (+128.4%) to their portfolio in Q2 2026, for an estimated $2,372,458,578
- JPMORGAN CHASE & CO added 12,207,565 shares (+inf%) to their portfolio in Q2 2026, for an estimated $878,334,301
- PACER ADVISORS, INC. added 6,360,931 shares (+inf%) to their portfolio in Q2 2026, for an estimated $457,668,985
- CANADA PENSION PLAN INVESTMENT BOARD added 4,860,917 shares (+inf%) to their portfolio in Q2 2026, for an estimated $349,742,978
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 4,841,988 shares (+8.9%) to their portfolio in Q2 2026, for an estimated $348,381,036
- BARCLAYS PLC removed 2,247,664 shares (-35.7%) from their portfolio in Q2 2026, for an estimated $161,719,424
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MO Price Targets
Multiple analysts have issued price targets for $MO recently. We have seen 3 analysts offer price targets for $MO in the last 6 months, with a median target of $70.0.
Here are some recent targets:
- Faham Baig from UBS set a target price of $79.0 on 07/07/2026
- Gaurav Jain from Barclays set a target price of $64.0 on 05/15/2026
- Simon Hales from Citigroup set a target price of $70.0 on 05/01/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
